H02.SI
Haw Par Corporation Limited [H02.SI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
H02.SI Stock Summary
In the News
H02.SI Financial details
Company Rating
-
Market Cap
2.15B
Income
175.23M
Revenue
197.69M
Book val./share
7.42
Cash/share
1.25
Dividend
0.35
Dividend %
3.61%
Employees
-
Optionable
No
Shortable
Yes
Earnings
23 Feb 2024
P/E
12.25
Forward P/E
-
PEG
2.04
P/S
10.85
P/B
1.31
P/C
7.75
P/FCF
92.49
Quick Ratio
2.53
Current Ratio
3.1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.8
EPS next Y
-
EPS next Q
-
EPS this Y
34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.72%
Revenue last 5Y
-5.2%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.62%
SMA50
-0.2%
SMA100
1.55%
Inst Own
-
Inst Trans
-
ROA
-
ROE
11%
ROC
-0.46%
Gross Margin
55%
Oper. Margin
26%
Profit Margin
89%
Payout
38%
Shs Outstand
221.37M
Shs Float
143.91M
-
-
-
-
Target Price
-
52W Range
9.11-11.38
52W High
-11.91%
52W Low
+7.67%
RSI
44.16
Rel Volume
0.63
Avg Volume
42.96K
Volume
27.1K
Perf Week
-0.62%
Perf Month
0.31%
Perf Quarter
5.33%
Perf Half Y
6.13%
-
-
-
-
Beta
0.446
-
-
Volatility
0.09%, 0.08%
Prev Close
0.62%
Price
9.69
Change
-0.92%
H02.SI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.08 | 1.1 | 0.5 | 0.64 | 0.82 | |
| Net income per share | 0.81 | 0.82 | 0.54 | 0.5 | 0.67 | |
| Operating cash flow per share | 0.31 | 0.38 | 0.11 | 0.09 | 0.18 | |
| Free cash flow per share | 0.3 | 0.37 | 0.08 | 0.07 | 0.1 | |
| Cash per share | 12.96 | 13.96 | 12.69 | 14.12 | 1.51 | |
| Book value per share | 13.26 | 14.27 | 13.05 | 14.51 | 7.1 | |
| Tangible book value per share | 13.21 | 14.22 | 13 | 14.46 | -0.5 | |
| Share holders equity per share | 13.26 | 14.27 | 13.05 | 14.51 | 7.1 | |
| Interest debt per share | 0.21 | 0.04 | 0.01 | 0 | 0 | |
| Market cap | 2.65B | 2.83B | 2.39B | 2.51B | 2.12B | |
| Enterprise value | 2.16B | 2.37B | 1.84B | 1.92B | 0 | |
| P/E ratio | 14.82 | 15.52 | 19.96 | 22.81 | 14.3 | |
| Price to sales ratio | 11.16 | 11.59 | 21.53 | 17.79 | 11.65 | |
| POCF ratio | 38.16 | 33.61 | 95.52 | 133.3 | 51.8 | |
| PFCF ratio | 40.1 | 34.84 | 136.73 | 173.71 | 100 | |
| P/B Ratio | 0.91 | 0.9 | 0.83 | 0.78 | 1.35 | |
| PTB ratio | 0.91 | 0.9 | 0.83 | 0.78 | 1.35 | |
| EV to sales | 9.07 | 9.72 | 16.55 | 13.57 | 0 | |
| Enterprise value over EBITDA | 10.85 | 11.65 | 14.04 | 15.62 | 0 | |
| EV to operating cash flow | 31.02 | 28.18 | 73.41 | 101.69 | 0 | |
| EV to free cash flow | 32.6 | 29.21 | 105.07 | 132.52 | 0 | |
| Earnings yield | 0.07 | 0.06 | 0.05 | 0.04 | 0.07 | |
| Free cash flow yield | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.02 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.02 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -2.5 | -2.24 | -4.23 | -4.85 | 0 | |
| Current ratio | 28.79 | 37.77 | 45.59 | 45.01 | 3.79 | |
| Interest coverage | 826.23 | 1.01K | 1.64K | 4.3K | 0 | |
| Income quality | 0.36 | 0.43 | 0.2 | 0.16 | 0.28 | |
| Dividend Yield | 0.02 | 0.09 | 0.03 | 0.03 | 0.03 | |
| Payout ratio | 0.31 | 1.4 | 0.55 | 0.6 | 0.45 | |
| Sales general and administrative to revenue | 0.05 | 0.06 | 0.12 | 0.08 | 0.1 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.05 | -0.04 | -0.3 | -0.23 | -0.48 | |
| Capex to revenue | -0.01 | -0.01 | -0.07 | -0.03 | -0.11 | |
| Capex to depreciation | -0.53 | -0.46 | -1.15 | -0.68 | -3.47 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 15.56 | 16.27 | 12.61 | 12.75 | 10.35 | |
| ROIC | 0.06 | 0.06 | 0.04 | 0.03 | 0 | |
| Return on tangible assets | 0.06 | 0.06 | 0.04 | 0.03 | -13.34 | |
| Graham Net | 12.56 | 13.62 | 12.44 | 13.82 | 1.1 | |
| Working capital | 2.83B | 3.05B | 2.78B | 3.1B | 280.09M | |
| Tangible asset value | 2.92B | 3.15B | 2.87B | 3.2B | -111.61M | |
| Net current asset value | 2.83B | 3.05B | 2.77B | 3.1B | 280.09M | |
| Invested capital | 0.02 | 0 | 0 | 0 | 0 | |
| Average receivables | -243.96M | 0 | 0 | 0 | 0 | |
| Average payables | 5.36M | 4.54M | 3.08M | 3.07M | 3.44M | |
| Average inventory | 20.8M | 22.31M | 17.73M | 14.25M | 16.21M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 22.75 | 11.69 | 16.46 | 18.06 | 15.46 | |
| Days of inventory on hand | 97.03 | 70.31 | 89.91 | 71.2 | 84.11 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 16.04 | 31.22 | 22.17 | 20.21 | 23.61 | |
| Inventory turnover | 3.76 | 5.19 | 4.06 | 5.13 | 4.34 | |
| ROE | 0.06 | 0.06 | 0.04 | 0.03 | 0.09 | |
| Capex per share | -0.02 | -0.01 | -0.03 | -0.02 | -0.09 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.22 | 0.2 | 0.2 | 0.25 | 0.25 | |
| Net income per share | 0.17 | 0.16 | 0.16 | 0.24 | 0.24 | |
| Operating cash flow per share | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Free cash flow per share | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Cash per share | 13.98 | 1.51 | 1.51 | 1.25 | 1.25 | |
| Book value per share | 14.56 | 7.1 | 7.1 | 7.42 | 7.42 | |
| Tangible book value per share | 14.56 | -0.5 | -0.5 | -0.54 | -0.54 | |
| Share holders equity per share | 14.56 | 7.1 | 7.1 | 7.42 | 7.42 | |
| Interest debt per share | 0.06 | 0 | 0 | 0 | 0 | |
| Market cap | 2.43B | 2.27B | 2.12B | 2.16B | 2.07B | |
| Enterprise value | 1.84B | 0 | 0 | 0 | 0 | |
| P/E ratio | 15.74 | 15.97 | 14.92 | 10.36 | 9.95 | |
| Price to sales ratio | 50.91 | 52.45 | 49.02 | 38.84 | 37.29 | |
| POCF ratio | 293.24 | 186.4 | 174.22 | 200.11 | 192.09 | |
| PFCF ratio | 386.69 | 526.03 | 491.64 | 296.41 | 284.54 | |
| P/B Ratio | 0.75 | 1.44 | 1.35 | 1.31 | 1.26 | |
| PTB ratio | 0.75 | 1.44 | 1.35 | 1.31 | 1.26 | |
| EV to sales | 38.62 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 156.98 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 222.44 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 293.33 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -49.97 | 0 | 0 | 0 | 0 | |
| Current ratio | 36.33 | 3.79 | 3.79 | 3.1 | 3.1 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.21 | 0.34 | 0.34 | 0.21 | 0.21 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.43 | 0.47 | 0.47 | 0.32 | 0.32 | |
| Sales general and administrative to revenue | 0.09 | 0.12 | 0.12 | 0.09 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.24 | -0.65 | -0.65 | -0.32 | -0.32 | |
| Capex to revenue | -0.04 | -0.18 | -0.18 | -0.06 | -0.06 | |
| Capex to depreciation | -1.4 | -5.55 | -5.55 | -2.38 | -2.38 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 7.56 | 5.06 | 5.06 | 6.26 | 6.26 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0.01 | -3.2 | -3.2 | -4.68 | -4.68 | |
| Graham Net | 13.62 | 1.1 | 1.1 | 0.8 | 0.8 | |
| Working capital | 3.06B | 280.09M | 280.09M | 229.44M | 229.44M | |
| Tangible asset value | 3.21B | -111.61M | -111.61M | -120.14M | -120.14M | |
| Net current asset value | 3.06B | 280.09M | 280.09M | 229.44M | 229.44M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 67.3M | 35.42M | 3.54M | 37.59M | 71.65M | |
| Average inventory | 15.9M | 17.57M | 19.25M | 19.19M | 19.13M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 277.76 | 15.95 | 15.95 | 267.73 | 267.73 | |
| Days of inventory on hand | 65.62 | 86.8 | 86.8 | 71.47 | 71.47 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.32 | 5.64 | 5.64 | 0.34 | 0.34 | |
| Inventory turnover | 1.37 | 1.04 | 1.04 | 1.26 | 1.26 | |
| ROE | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Capex per share | -0.01 | -0.04 | -0.04 | -0.02 | -0.02 |
H02.SI Frequently Asked Questions
What is Haw Par Corporation Limited stock symbol ?
Haw Par Corporation Limited is a SG stock and trading under the symbol H02.SI
What is Haw Par Corporation Limited stock quote today ?
Haw Par Corporation Limited stock price is $9.69 today.
Is Haw Par Corporation Limited stock public?
Yes, Haw Par Corporation Limited is a publicly traded company.
Company Profile
- Volume Average 42.96K
- Market Capitalization 2.15B
- CEO Mr. Ee Lim Wee
- Headquarters Singapore,SG
- IPO Date 2000-01-03
-
Website
https://www.hawpar.com 
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.
